| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,366 |
12,528 |
$5.58M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,288 |
28,359 |
$2.16M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,842 |
1,681 |
$955K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,575 |
4,870 |
$238K |
| 87428 |
|
3,119 |
3,050 |
$169K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,791 |
2,739 |
$166K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,975 |
16,214 |
$119K |
| 80053 |
Comprehensive metabolic panel |
14,984 |
13,626 |
$116K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,229 |
2,185 |
$99K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,249 |
2,203 |
$79K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,073 |
1,046 |
$73K |
| 99215 |
Prolong outpt/office vis |
833 |
828 |
$73K |
| G0378 |
Hospital observation service, per hour |
54 |
50 |
$68K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,045 |
2,982 |
$68K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
500 |
470 |
$68K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
580 |
524 |
$53K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,528 |
2,457 |
$48K |
| 71045 |
Radiologic examination, chest; single view |
3,090 |
2,855 |
$47K |
| D0120 |
Periodic oral evaluation - established patient |
1,519 |
1,519 |
$43K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,225 |
1,150 |
$42K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
916 |
886 |
$31K |
| D1120 |
Prophylaxis - child |
830 |
830 |
$30K |
| 81001 |
|
8,984 |
8,185 |
$26K |
| D1208 |
Topical application of fluoride, excluding varnish |
1,602 |
1,602 |
$23K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
43 |
42 |
$22K |
| 76801 |
|
247 |
213 |
$20K |
| 84484 |
|
3,503 |
2,654 |
$20K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,661 |
2,457 |
$18K |
| 87081 |
|
1,902 |
1,862 |
$18K |
| D1110 |
Prophylaxis - adult |
267 |
267 |
$14K |
| 83690 |
|
3,009 |
2,769 |
$14K |
| 84702 |
|
1,011 |
870 |
$12K |
| 83880 |
|
1,109 |
1,030 |
$12K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
175 |
143 |
$12K |
| 84703 |
|
1,641 |
1,520 |
$10K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,546 |
2,860 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
215 |
203 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
157 |
149 |
$9K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
280 |
131 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
175 |
164 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,132 |
1,752 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
161 |
161 |
$6K |
| 43235 |
|
13 |
13 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
343 |
333 |
$6K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
246 |
233 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,165 |
1,062 |
$5K |
| 82803 |
|
563 |
497 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
159 |
155 |
$5K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,158 |
1,867 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,187 |
1,081 |
$5K |
| 94760 |
|
221 |
137 |
$4K |
| 83605 |
|
887 |
702 |
$4K |
| 87420 |
|
163 |
160 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
44 |
44 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,136 |
969 |
$3K |
| D0220 |
Intraoral - periapical first radiographic image |
292 |
288 |
$3K |
| D0272 |
Bitewings - two radiographic images |
143 |
143 |
$3K |
| 85610 |
|
2,035 |
1,871 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
780 |
566 |
$3K |
| 85730 |
|
1,578 |
1,464 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,069 |
1,705 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
202 |
192 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
56 |
54 |
$2K |
| 83735 |
|
1,123 |
907 |
$2K |
| 82375 |
|
510 |
457 |
$2K |
| 73564 |
|
34 |
32 |
$2K |
| 82330 |
|
563 |
505 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
36 |
24 |
$2K |
| 0240U |
|
570 |
556 |
$2K |
| 81025 |
|
288 |
263 |
$2K |
| D0145 |
Oral evaluation for a patient under three years of age |
15 |
15 |
$2K |
| 83050 |
|
494 |
444 |
$2K |
| 93976 |
|
17 |
14 |
$1K |
| 85027 |
|
958 |
807 |
$1K |
| D1351 |
Sealant - per tooth |
48 |
13 |
$1K |
| 86850 |
|
93 |
79 |
$1K |
| D0274 |
Bitewings - four radiographic images |
44 |
44 |
$1K |
| 87040 |
|
268 |
137 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
21,297 |
18,048 |
$991.20 |
| D0230 |
Intraoral - periapical each additional radiographic image |
95 |
38 |
$955.33 |
| 84443 |
Thyroid stimulating hormone (TSH) |
235 |
221 |
$937.50 |
| 72100 |
|
12 |
12 |
$903.50 |
| 86900 |
|
569 |
504 |
$878.37 |
| 86901 |
|
569 |
504 |
$850.42 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
567 |
419 |
$800.75 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
547 |
419 |
$767.64 |
| 80320 |
|
70 |
66 |
$761.11 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
425 |
373 |
$734.77 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
450 |
389 |
$696.55 |
| 81003 |
|
706 |
663 |
$653.29 |
| 87186 |
|
195 |
158 |
$581.32 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
287 |
240 |
$553.22 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
172 |
163 |
$484.81 |
| 82077 |
|
45 |
40 |
$462.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
251 |
231 |
$448.53 |
| 84132 |
|
309 |
282 |
$425.85 |
| 82435 |
|
283 |
258 |
$395.30 |
| 80076 |
|
58 |
56 |
$392.44 |
| 84295 |
|
251 |
232 |
$379.87 |
| 82947 |
|
284 |
259 |
$348.15 |
| 87077 |
|
111 |
99 |
$303.43 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
81 |
80 |
$241.00 |
| D0140 |
Limited oral evaluation - problem focused |
12 |
12 |
$225.36 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
91 |
48 |
$177.39 |
| 73030 |
|
12 |
12 |
$153.50 |
| 80179 |
|
13 |
12 |
$133.42 |
| 80143 |
|
13 |
12 |
$133.42 |
| 80061 |
Lipid panel |
27 |
25 |
$105.75 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
200 |
173 |
$101.24 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
79 |
62 |
$92.89 |
| 82962 |
|
2,390 |
975 |
$82.67 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13 |
12 |
$62.60 |
| J1644 |
Injection, heparin sodium, per 1000 units |
17 |
12 |
$57.25 |
| 96376 |
|
71 |
53 |
$21.17 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
25 |
25 |
$17.92 |
| 84100 |
|
14 |
12 |
$14.96 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
14 |
12 |
$13.27 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
427 |
394 |
$13.00 |
| A9270 |
Non-covered item or service |
2,646 |
1,582 |
$7.82 |
| J2704 |
Injection, propofol, 10 mg |
153 |
120 |
$2.02 |
| D0603 |
|
1,203 |
1,203 |
$0.00 |
| D0602 |
|
275 |
275 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
14 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
152 |
145 |
$0.00 |
| A6021 |
Collagen dressing, sterile, size 16 sq. in. or less, each |
27 |
12 |
$0.00 |
| 77080 |
|
28 |
28 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
13 |
$0.00 |